Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M003024200 on August 4, 2000

J. Biol. Chem., Vol. 275, Issue 42, 33123-33133, October 20, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/42/33123    most recent
M003024200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefai, E.
Right arrow Articles by Garesse, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefai, E.
Right arrow Articles by Garesse, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Regulation of the Catalytic and Accessory Subunit Genes of Drosophila Mitochondrial DNA Polymerase*

Etienne LefaiDagger §, Miguel A. Fernández-MorenoDagger §, Anuradha Alahari||, Laurie S. Kaguni||, and Rafael GaresseDagger **

From the Dagger  Departamento de Bioquímica, Instituto de Investigaciones Biomédicas "Alberto Sols" CSIC-UAM, Facultad de Medicina, Universidad Autónoma de Madrid, c/Arzobispo Morcillo 4, 28029 Madrid, Spain and the || Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824-1319

Received for publication, April 11, 2000, and in revised form, July 25, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The developmental pattern of expression of the genes encoding the catalytic (alpha ) and accessory (beta ) subunits of mitochondrial DNA polymerase (pol gamma ) has been examined in Drosophila melanogaster. The steady-state level of pol gamma -beta mRNA increases during the first hours of development, reaching its maximum value at the start of mtDNA replication in Drosophila embryos. In contrast, the steady-state level of pol gamma -alpha mRNA decreases as development proceeds and is low in stages of active mtDNA replication. This difference in mRNA abundance results at least in part from differences in the rates of mRNA synthesis. The pol gamma  genes are located in a compact cluster of five genes that contains three promoter regions (P1-P3). The P1 region directs divergent transcription of the pol gamma -beta gene and the adjacent rpII33 gene. P1 contains a DNA replication-related element (DRE) that is essential for pol gamma -beta promoter activity, but not for rpII33 promoter activity in Schneider's cells. A second divergent promoter region (P2) controls the expression of the orc5 and sop2 genes. The P2 region contains two DREs that are essential for orc5 promoter activity, but not for sop2 promoter activity. The expression of the pol gamma -alpha gene is directed by P3, a weak promoter that does not contain DREs. Electrophoretic mobility shift experiments demonstrate that the DRE-binding factor (DREF) regulatory protein binds to the DREs in P1 and P2. DREF regulates the expression of several genes encoding key factors involved in nuclear DNA replication. Its role in controlling the expression of the pol gamma -beta and orc5 genes establishes a common regulatory mechanism linking nuclear and mitochondrial DNA replication. Overall, our results suggest that the accessory subunit of mtDNA polymerase plays an important role in the control of mtDNA replication in Drosophila.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Animal mitochondrial DNAs, with few exceptions, encode 13 subunits of the respiratory complexes I and III-V located in the inner mitochondrial membrane. The remainder of the ~1000 mitochondrial proteins, including those involved in mtDNA replication and transcription, are encoded in the nucleus, translated on cytoplasmic ribosomes, and targeted by a complex import mechanism to the mitochondrial compartment (1, 2).

The molecular mechanisms involved in mitochondrial proliferation and maturation (i.e. mitochondrial biogenesis) during cell division, growth, and differentiation are poorly understood. During early embryonic stages, the mitochondria that are stored in the oocyte are segregated into various cellular territories; as development proceeds, mitochondrial proliferation begins. When differentiation ceases, the cells contain the correct number of mitochondria with the specific morphology and intracellular distribution to meet the highly variable energetic requirements of the various tissues of the organism (3, 4). How the mitochondrial mass, the extent of mitochondrial differentiation, and the mtDNA copy number are controlled in a defined cell type is not known.

In addition to this increase in mitochondrial biogenesis in response to unidentified developmental cues, cells can also regulate the expression of the genes encoding mitochondrial proteins in response to a variety of physiological signals, including hormones, cyclic nucleotides, contractile activity, and thermogenesis (5-8). Several DNA elements recognized by regulatory proteins involved in the transcriptional regulation of nuclearly encoded mitochondrial genes have been identified in mammals, including Mts, REBOX/OXBOX, and GRBOX elements (9-11). In addition, two transcription factors involved in nucleo-mitochondrial communication, nuclear respiratory factors 1 and 2 (NRF1 1 and NRF2), have been characterized during the last few years by Scarpulla and co-workers (12-14). NRF1 activates the expression of several genes that encode functional components of the oxidative phosphorylation pathway and key elements of the transcriptional/replication machinery of mitochondria such as Tfam (also known as mitochondrial transcription factor A) and the RNase mitochondrial RNA processing (7). Binding sites for NRF1 have been also identified in several genes involved in cell proliferation and intermediary metabolism (12). Thus, NRF1 likely plays an important role in the control of mammalian mitochondrial biogenesis under a variety of conditions requiring high energy supply.

Although mtDNA replication is required for eukaryotic cell proliferation, the mechanisms that regulate this process are poorly understood. Recent studies have shown that the cytoskeleton plays an active role in the mitochondrial dynamics of the cell (for a review, see Ref. 15) and that the replication of the mitochondrial genome occurs in the perinuclear space (16). The key enzyme in mtDNA replication is DNA polymerase gamma  (pol gamma ), which constitutes only ~1% of the total cellular DNA polymerase activity (17, 18). The pol gamma  holoenzyme has been characterized extensively in Drosophila (19); it is a heterodimer of a 125-kDa alpha  subunit containing DNA polymerase and 3'-5' exonuclease catalytic activities (20) and a 35-kDa accessory subunit that increases the catalytic efficiency of the holoenzyme and is likely involved in primer recognition and in enhancing processivity (21, 22). Both subunits have also been identified in other systems, and their structures are evolutionarily conserved. The catalytic subunit shares homology with the family A DNA polymerases (20, 23, 24), whereas the accessory subunit is related to aminoacyl-tRNA synthetases (22, 25). In Drosophila, the nuclear genes and the corresponding cDNAs have been cloned (20, 26, 27) and map in the same genomic region (Adh region, chromosome II) within a tight cluster of five genes (28). Here we report on the transcriptional regulation of the pol gamma -alpha and pol gamma -beta genes. Whereas our data indicate that the catalytic subunit of pol gamma  is expressed constitutively at a low level, the developmental pattern of expression of the pol gamma -beta gene suggests that the accessory subunit plays an important role in the control of mtDNA replication. Moreover, the transcription factor DREF, which activates the expression of genes encoding components of the nuclear replication machinery (29), is critical for pol gamma -beta promoter activity. This regulatory protein is also critical for the activity of the mitochondrial single-stranded DNA-binding protein (mtSSB) promoter (30), establishing firmly a molecular link between nuclear and mitochondrial DNA replication.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

RNA Extraction and Northern Analysis

Total RNAs from staged embryos; first-, second-, and third-instar larvae; early and late pupae; and adults of Drosophila melanogaster Oregon R were extracted using the Trizol kit (Life Technologies, Inc.) according to the manufacturer's directions. For Northern analysis, 30 µg of total RNA was electrophoresed on 1.8 M formaldehyde and 1.2% agarose gels, blotted on a Zeta Probe membrane (Bio-Rad), and probed in ZAP buffer (0.25 M phosphate buffer, pH 7.2., 7% SDS) at 65 °C using various [alpha -32P]dCTP-labeled cDNA clones as probes. Filters were washed in 0.1% SDS and 0.1× SSC at 65 °C and autoradiographed with intensifying screens at -70 °C.

Nuclear Run-on Transcription Analysis

To obtain nuclei from Drosophila adults, flies (100 in a typical experiment) were homogenized in 1 ml of buffer containing 10 mM KCl, 15 mM HEPES (pH 7.6), 5 mM MgCl2, 0.35 M sucrose, 0.5 mM EGTA, 0.1 mM EDTA, 1 mM dithiothreitol, and 10 mM phenylmethylsulfonyl fluoride. The homogenate was filtered through Miracloth (Calbiochem) and centrifuged at 400 × g for 5 min. The supernatant was centrifuged at 700 × g for 10 min, and the nuclear pellet was resuspended in buffer containing 50 mM Tris-HCl (pH 8.3), 5 mM MgCl2, 0.1 mM EDTA, and 40% glycerol. Embryos were dechorionated by sodium hypochloride treatment and washed extensively before homogenization. Transcriptional run-on reactions were performed essentially as described by Linial et al. (31) using 150 µCi of [alpha -32P]UTP and ~107 nuclei. Radiolabeled RNA was purified by phenol/chloroform extraction followed by precipitation with isopropyl alcohol and hybridized in ZAP buffer at 65 °C to 5 µg of 18 S rDNA and pol gamma -alpha and pol gamma -beta cDNAs that were immobilized on nylon filters using the Manifold II system (Schleicher & Schüll) and denatured by NaOH treatment. Filters were washed in 0.1% SDS and 02 × SSC at 65 °C and autoradiographed with intensifying screens at -70 °C.

Promoter Constructs

DNA fragments containing the promoter regions (P1-P3) of the five genes were amplified by PCR using several sets of oligonucleotide primers (Table I). The resulting parental DNA fragments were used as substrates for generation of deletion constructs. After digestion with restriction endonucleases, DNA fragments were excised from agarose gels and inserted into the pxp2 vector, which contains the luciferase gene as reporter. The nucleotide sequences of the parental DNA fragments and each of the promoter constructs were confirmed by DNA sequence analysis.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Oligonucleotide primers used in this study
+1 represents the transcriptional start site of pol gamma -beta , orc5, and pol gamma -alpha , respectively. The XhoI restriction sites included in the reverse oligonucleotides are underlined. Their positions are according to +1.

pol gamma -alpha Promoter (P3)-- Deletions of the parental DNA fragment were generated as follows. EcoRV/XhoI and XmnI/XhoI fragments were cloned into the pxp2 vector that was digested with SmaI/XhoI to generate constructs alpha -1710/+113 and alpha -1197/+113 (where +1 corresponds to the transcriptional start site). The XmnI/XhoI fragment was also digested with DraI, and the XmnI/DraI fragment was cloned into pxp2 that was digested with SmaI to generate construct alpha -1197/-183. To obtain construct alpha -407/+113, a 520-bp BglII/XhoI fragment was cloned into pxp2 that was digested with BglII/XhoI. To mutate the putative NRF1-like binding site in P3, we used the oligonucleotide 5'-GCCAGCCTAGGTATTTTTGccCcCTccCcCGGCGG-3' (from positions +42 to +8 in the template strand for transcription); the lowercase letters represent the nucleotides that were changed from the original sequence (5'-GCCAGCCTAGGTATTTTTGTGCGCTTGCGCGGCGG-3'), and those that are underlined represent the mutated NRF1 site. After several steps of subcloning, PCR, and additional subcloning, construct alpha -407/+113mut was obtained. This plasmid is identical to its parental construct, alpha -407/+113, except for the six nucleotide changes within the NRF1-like site.

rpII33/pol gamma -beta Promoter (P1)-- Deletions in the parental PCR fragment were generated as follows. HindIII/XhoI and PvuII/XhoI fragments were cloned into the pxp2 vector that was digested with HindIII/XhoI and SmaI/XhoI, respectively, to generate constructs beta -1806/+467 and beta -1319/+467. To obtain constructs beta -569/+467 and beta -212/+467, the parental DNA fragment was digested with PstI and then with ClaI, rendered blunt-ended with T4 DNA polymerase, and cut with XhoI. Purified fragments were then ligated into the pxp2 vector that was digested with SmaI/XhoI. A 797-bp DNA fragment from positions -326 to +473 was also amplified by PCR using two oligonucleotides as primers: the same reverse primer described above (Table I) and a new forward primer (5'-GCACTGCAGTTTTGTTTTGATGAA-3') containing a PstI site at position -318. The amplified product was digested with PstI and XhoI and cloned into the pBluescript vector that was digested with the same restriction enzymes, generating pBS-PI. The construct was then digested with ClaI; end-filled with Klenow DNA polymerase; and religated to obtain pBS-PImut, in which the DREF-binding site is changed from TATCGATT to TATCgcGATT. The BamHI/XhoI fragments of pBS-PI and pBS-PImut were cloned into pxp2 that was digested with BamHI/XhoI to generate the beta -318/+467 and beta -318/+467mut constructs, respectively.

The BamHI/XhoI fragments of pBS-PI and pBS-PImut were also cloned into pxp2 that was digested with BamHI/XhoI to generate constructs rpII-715/+71 and rpII-715/+71mut, with the inverse orientation of the DNA fragments. These constructs are numbered with respect to the transcriptional start site (+1) of the rpII33 gene.

orc5/sop2 Promoter (P2)-- Deletions of P2 were generated by digestion of the parental PCR fragment as follows. The HindIII/XhoI and SalI/XhoI fragments were cloned into pxp2 that was digested with the same enzymes to generate constructs sop-1616/+307 and sop-604/+307. (+1 represents the transcriptional start site in the sop2 gene that maps at a position 326 nucleotides upstream of the translational start codon. This +1 position is shared in the complementary strand by the orc5 gene.) A 627-bp DNA fragment from positions -326 to +473 was amplified by PCR using two oligonucleotides as primers: the same reverse primer described above (Table I) and a forward primer (5'-CCAGAGCTCTCGTCTGCTTT-3') containing a PvuII site at position -306. The PvuII/XhoI fragment was cloned into the pBluescript vector that was digested with EcoRV/XhoI to obtain construct pBS-PII. The construct was then digested with ClaI; end-filled with Klenow DNA polymerase; and religated to obtain construct pBS-PIImut, in which the region containing the two DREF sites is modified by a small deletion, changing the sequence TATCGATataacgaaaTAACGATAgtattgagggccatcgatt, where the ClaI sites are underlined and the DREF sites are in uppercase letters. The BamHI/XhoI fragments of pBS-PII and pBS-PIImut were cloned into pxp2 that was digested with BamHI/XhoI to obtain constructs sop-303/+307 and sop-303/+307mut. A 2230-bp DNA fragment from positions -2080 to +351 (where +1 corresponds to the transcriptional start site of the orc5 gene) was amplified by PCR using the two oligonucleotide primers 5'-CCAGAGCTCTCGTCTGCTTT-3' (forward) and 5'-GGCCCTCGAGGGTGGCTAAATGCG-3' (reverse), in which a PvuII site was introduced at a position corresponding to +343. The SalI/PvuII fragment was cloned into pxp2 that was digested with SalI/SmaI to generate construct orc-1405/+346. The SalI/KpnI fragment was cloned into pxp2 that was digested with SalI/KpnI to generate construct orc-1405/+117. Finally, the BamHI/EcoRV fragments of pBS-PII and pBS-PIImut were cloned into pxp2 that was digested with SmaII/BglII to obtain the orc-170/+346 and orc-170/+346mut constructs, respectively.

DREF and Erect Wing Constructs-- For cotransfection experiments, we cloned the complete Erect Wing (EWG) and DREF cDNAs in the vector pMK26 (32), which allows strong expression under the control of the actin 5C promoter. A BamHI/XhoI fragment containing the complete DREF cDNA (30) was end-filled with Klenow DNA polymerase and subcloned into the pBluescript vector that was digested with EcoRV to obtain pBS-DREF. For EWG plasmid construction, the pET3dEWG6His clone (a kind gift of Dr. Richard Scarpulla) was first digested with XbaI/BamHI, end-filled with Klenow DNA polymerase, and then inserted into the pBluescript vector that was digested with EcoRV to obtain pBS-EWG. Finally, the HindIII/PstI fragments obtained from pBS-DREF and pBS-EWG were cloned into the pMK26 vector that was digested with HindIII/PstI, generating constructs pMK-DREF and pMK-EWG, respectively.

Cell Transfection and Reporter Activity

Transfection in Schneider's S2 cells was carried out according to Soeller et al. (33) with some modifications. Streptomycin (100 µg/ml) and penicillin (100 IU/ml) were added to the medium, and cells were transfected with 10 µg of the vector pSVbeta gal (Promega) and 5 µg of the corresponding pxp construct. After transfection, cells were incubated for 24 h at 25 °C, washed twice with phosphate-buffered saline, resuspended in 5 ml of fresh medium, and incubated for 60-80 h at 25 °C. To prepare extracts, cells were harvested by centrifugation; washed with phosphate-buffered saline and then with fresh buffer containing 40 mM Tris-HCl (pH 7.5), 1 mM EDTA, and 150 mM NaCl; resuspended in 100 µl of 0.1 M Tris-HCl (pH 7.5); and subjected to five cycles of freezing for 60 s at -70 °C and heating for 60 s at 37 °C. Cell debris was removed by centrifugation at 13,000 × g for 5 min. Promoter activities were calculated by normalizing luciferase activity (pxp constructs) to beta -galactosidase activity (pSVbeta gal). Luciferase activity was determined using the luciferase assay system (Promega) according to the manufacturer's recommendations, and beta -galactosidase activity was measured as described previously (34).

Electrophoretic Mobility Shift Assays

Electrophoretic mobility shift assays (EMSAs) were carried out using protein prepared from two sources: the in vitro TNT transcription/translation system (Promega) for DREF binding assays and Schneider's cell nuclear extracts for DREF and NRF1 binding assays. The binding reactions were carried out using 2 µl of in vitro transcription and translation product or 5 µg of nuclear protein and 50,000 cpm of the DNA probe in binding buffer containing 20% glycerol, 1 mM dithiothreitol, 20 mM HEPES (pH 9.0), 5 mM MgCl2, 0.2 mM EDTA, and 200 mM KCl. After incubation for 30 min at 4 °C, reaction products were electrophoresed on 4.5% polyacrylamide gels (for PCR probes) or 6% polyacrylamide gels (for oligonucleotide probes) containing 0.5× Tris borate/EDTA. DNA probes were labeled using [gamma -32P]ATP and T4 polynucleotide kinase. For the P1 probes, two DNA fragments containing the DRE were used as probes: a double-stranded 30-mer oligonucleotide from positions -225 to -204 and a 173-bp fragment from positions -325 to -153 that was obtained by PCR amplification (where +1 corresponds to the transcriptional start site for pol gamma -beta ). For the P2 probe, a 120-bp DNA fragment from positions -132 to -13 containing the DREs was amplified by PCR (where +1 corresponds to the transcriptional start site for sop2). In DREF EMSA experiments, a 100-fold molar excess of various oligonucleotides was used as competitor, including unlabeled DNA probes and oligonucleotides from the mtSSB promoter containing wild-type or mutated DRE sites (30). For the P3 probe, a double-stranded 35-mer oligonucleotide from positions +42 to +8 containing the NRF1-like site and its mutated version (described above) was used. DREF antiserum was prepared as described (30). Antiserum against EWG was kindly provided by Dr. Kalpana White. In supershift assays, 2 µl of a 1:100 dilution of the relevant antiserum was used.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Differential Expression of the Genes Encoding the pol gamma  Catalytic and Accessory Subunits during D. melanogaster Development-- The genes encoding the two subunits of the mitochondrial DNA polymerase map within a cluster of genes, the pol gamma  cluster, that extends over a region of 10.5 kilobases in the alcohol dehydrogenase region (34D-E) of the second chromosome of D. melanogaster (27, 28). The cluster contains five genes that encode proteins involved in essential cellular processes, including the two pol gamma  subunits (pol gamma -alpha and pol gamma -beta ), one subunit of RNA polymerase II (RpII33), one subunit of the origin recognition complex (ORC5), and one subunit of the actin-related protein 2/3 complex (SOP2/ARC41). The pol gamma  cluster is extremely compact: the genes are tightly packed with very little intergenic space, with some overlap in their 5'- and 3'-ends (Fig. 1). The cluster contains three promoter regions (P1-P3), and two of them direct bidirectional transcription (28). This tight organization suggests that the structure of the pol gamma  cluster plays an important role in regulating the expression of its genes. This is a particularly important consideration given that two of the genes encode the subunits of the key enzyme in the mitochondrial DNA replication process (pol gamma -alpha and pol gamma -beta ), representing a rare example in eukaryotes of genes encoding functionally related proteins that are linked in the genome. Moreover, a third gene of the pol gamma  cluster, orc5, encodes an essential component of the nuclear DNA replication machinery, suggesting the presence of potential common regulatory mechanisms for nuclear and mitochondrial DNA replication.


View larger version (6K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the Drosophila pol gamma  gene cluster. The structure and direction of transcription of the five genes in the pol gamma  cluster are shown schematically. Thick arrows represent the protein coding regions, and thin arrows indicate the transcriptional start sites. Stippled boxes represent 5'- and 3'-untranslated regions, and open boxes represent introns. P1-P3 correspond to the three promoter regions that direct transcription within the cluster. Kb, kilobases.

As a first step to study the factors involved in regulating the expression of the pol gamma  genes, we determined (by Northern analysis) their patterns of expression during Drosophila development and compared them with the expression profiles of the other genes encoded in the pol gamma  cluster. The level of pol gamma -alpha mRNA was relatively high in eggs and decreased rapidly during embryonic development (Fig. 2A). This result is perhaps surprising because mtDNA replication started ~10 h after egg laying (AEL); and at this developmental stage, the level of pol gamma -alpha mRNA has declined substantially. During the larval stages, a period characterized by increases in body weight and cell ploidy, the steady-state level of pol gamma -alpha mRNA remained very low, whereas that in adults was comparatively higher. The spatiotemporal pattern of expression of pol gamma -alpha mRNA, examined by whole-mount RNA in situ hybridization, is in good agreement with the Northern results. pol gamma -alpha mRNA was distributed homogeneously in early blastoderm, and the intensity of the signal decreased through gastrulation and was very faint or undetectable in older embryos (data not shown).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 2.   Developmental pattern of expression of the five genes encoded in the Drosophila pol gamma  cluster. Total RNAs from 0-18-h embryos, larvae (first-, second-, and third-instar (L1-L3, respectively)), pupae (P1-P3), and adults (A) of D. melanogaster were analyzed by Northern blotting using the corresponding cDNAs as probes. RNAs were fractionated on formaldehyde-containing 1.2% agarose gels, transferred to nylon membrane, and hybridized with the corresponding radiolabeled probes, and the blots were autoradiographed. Levels of RNA loaded were evaluated by ethidium bromide (EthBr) staining. The expression patterns of the pol gamma  genes are shown in A, and those of rpII33, sop2, and orc5 are shown in B.

pol gamma -beta mRNA showed a different developmental profile (Fig. 2A). The level present in eggs was relatively low, but its steady-state level increased in early embryonic stages, reaching its maximum between 6 and 12 h AEL. In late embryos, its steady-state level decreased; and in first-instar larvae, there was a moderate increase. These results suggest that the expression of the pol gamma -beta subunit is regulated precisely during Drosophila development. Moreover, the steady-state level of pol gamma -beta reached its maximum just before the start of mtDNA synthesis that occurred 10-12 h AEL.

To determine whether the differences observed in the pattern of expression of pol gamma -alpha and pol gamma -beta mRNAs are due to different rates of transcription, we performed a series of run-on transcription experiments using nuclei extracted from 8-10-h AEL embryos and adults. A higher rate of mRNA synthesis was detected in the pol gamma -beta gene in both embryos and adults (Fig. 3). Although we have not evaluated possible differences in mRNA stability, the different rates of mRNA synthesis correspond well with the mRNA steady-state levels detected by Northern analysis (Fig. 2A), documenting a differential regulation of the pol gamma -alpha and pol gamma -beta genes at the transcriptional level.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Nuclear run-on transcription analysis of the pol gamma -alpha and pol gamma -beta genes. The relative rates of transcription of the pol gamma -alpha and pol gamma -beta genes were evaluated in run-on experiments as described under "Experimental Procedures." A, nuclei obtained from adults and 8-10-h AEL embryos were labeled with [alpha -32P]UTP. The RNA synthesized de novo was hybridized to 5 µg of 18 S rDNA (as a control), pol gamma -alpha cDNA, and pol gamma -beta cDNA immobilized on a nylon membrane. B, shown is the densitometric quantitation of the data obtained in four independent experiments. Values are expressed in arbitrary units.

Unfortunately, we were unable to detect pol gamma -beta mRNA by in situ hybridization despite systematic attempts using a variety of experimental conditions (data not shown). A lack of sensitivity of the technique is an unlikely explanation because Northern analysis showed that the steady-state level of pol gamma -beta mRNA was similar or higher than that of pol gamma -alpha mRNA. We have also used in parallel several control probes that detect other unrelated mRNAs, obtaining in each case the expected pattern. Although the reason for the lack of in situ detection of pol gamma -beta mRNA is presently unknown, our data suggest the possibility of some type of sequestration of pol gamma -beta mRNA that does not occur with pol gamma -alpha mRNA.

The rpII33 gene is divergently transcribed from the same promoter as the pol gamma -beta gene, yet its developmental pattern of expression is entirely different (Fig. 2B). rpII33 mRNA was accumulated in eggs, and its level was maintained fairly constant during early embryogenesis up to 6 h AEL. From 9 h AEL onward, its steady-state level decreased and was very low during the larval and pupal periods. Adults also contained a relatively low amount of the rpII33 transcript. A similar result was observed in the case of the orc5/sop2 genes, and the pattern of expression was also different for each gene (Fig. 2B). sop2 mRNA was present at relatively high levels in all developmental stages, whereas the steady-state level of orc5 mRNA was very high in eggs and decreased sharply as development proceeded. In larvae and pupae, its concentration was low and increased again in adults. This pattern is generally similar to that for pol gamma -alpha . Our results indicate clearly that the pairs of genes transcribed from the bidirectional promoters P1 and P2 are differentially regulated during development.

Analysis of the rpII33/pol gamma -beta Promoter Region (P1)-- The developmental pattern of expression of the pol gamma -beta gene suggests that the accessory subunit of the pol gamma  enzyme may play an important role in regulating mtDNA replication. The pol gamma -beta gene is divergently transcribed from the rpII33 gene, and their 5'-ends are separated by only 245 bp (Fig. 1). To identify and characterize transcriptional regulatory elements in the rpII33/pol gamma -beta intergenic promoter region (P1), we cloned defined DNA fragments in the pxp2 vector and determined their promoter activities in transient transfection experiments in Schneider's S2 cells, measuring luciferase activity in cell extracts (see "Experimental Procedures").

A construct containing the 5'-UTR and 1.8 kilobases of the proximal 5'-upstream region of the pol gamma -beta gene (beta -1806/+467, where +1 corresponds to the pol gamma -beta transcriptional start site), which includes the complete adjacent rpII33 gene, directed a substantial level of luciferase activity in Schneider's cells, >1000-fold as compared with the pxp2 vector (Fig. 4). A similar level of activity was maintained in shorter constructs, including beta -318/+467, which contains the rpII33/pol gamma -beta intergenic region and the 5'-UTRs of both genes. Computer analysis of the DNA sequence spanning positions -318 to +467 revealed the presence of a DRE motif (TATCGATT) located at position -216 within the rpII33/pol gamma -beta intergenic region, close (~30 bp) to the transcriptional initiation site of the rpII33 gene. The DRE is recognized by DREF, a transcription factor critical in the regulated expression of several genes encoding proteins involved in nuclear DNA replication (29). We have also demonstrated recently that it is essential for the activity of the D. melanogaster mtSSB promoter (30). Mutation of the DRE-binding site reduced the activity of construct beta -318/+467mut by 80% (p < 0.05), suggesting strongly that DREF is critical to achieve full pol gamma -beta promoter activity. Furthermore, construct beta -212/+417, with the DRE site eliminated, abolished promoter activity in Schneider's cells.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Functional analysis of the P1 region. A schematic representation of the divergent P1 region and the adjacent pol gamma -beta and rpII33 genes is shown in the middle. Thick arrows represent the protein coding regions; stippled boxes represent 5'-untranslated regions; and open boxes represent introns. Transcriptional initiation sites (+1) are indicated by thin arrows, and the positions of translational initiation sites are indicated as ATG with a corresponding number that indicates the length of the 5'-untranslated region. The DRE sequence is represented as an ellipse. DNA fragments cloned upstream of the luciferase reporter gene and used in the analysis of the pol gamma -beta promoter activity are shown above the schematic, and those used in the analysis of the rpII33 promoter activity are shown below. Plasmid designations indicate the specific DNA sequences present in the constructs, with numbers relative to the position of the transcriptional start site. The internal X in the DRE sequence indicates that the site is mutated. The relative promoter activities of the constructs, as measured in the luciferase assay, are indicated to the right. The luciferase activity of the pxp2 vector was defined as 1.0 and was used as the standard for comparison. Luciferase activity was normalized to beta -galactosidase activity for each construct. Values are means ± S.D. of at least three independent experiments. Statistical analysis was carried out using the Wilcoxon signed-rank test. * indicates p < 0.05.

To determine whether the DRE sequence is also important for the activity of the rpII33 promoter, we determined the luciferase activity of the beta -318/+467 fragment cloned in the pxp2 vector in the opposite orientation (rpII-715/+71). An 800-fold induction in luciferase activity was detected, indicating that the rpII33/pol gamma -beta intergenic region divergently directs the transcription of the two genes. Importantly, when the assay was carried out with a construct containing the same DNA fragment with the DRE site mutated (rpII-715/+71mut), no significant change in luciferase activity was observed. This result demonstrates that the DRE site located in the P1 region is essential only for the promoter activity of the pol gamma -beta gene.

Analysis of the orc5/sop2 Promoter Region (P2)-- Two of the genes in the pol gamma  cluster, orc5 and sop2, overlap in their 5'-ends (Fig. 1). We found that a DNA fragment encompassing the 5'-upstream region of the two genes contains potent bidirectional promoter activity. Construct sop-1616/+307, which contains the sop2 5'-UTR and most of the orc5 gene, directed a high level of luciferase activity, >9000-fold as compared with the pxp2 vector (Fig. 5). A high level of activity was maintained in the sop-303/+307 construct, which contains the complete 5'-UTRs of the two overlapping genes. The 5'-UTR of the orc5 gene contains two DRE sites. To examine the functional relevance of the DRE sites in sop2 promoter activity, we mutated both sites in construct sop-303/+307mut. We observed no change in the level of luciferase activity, indicating that the DRE sites do not play an essential role in the sop2 promoter activity in Schneider's cells.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Functional analysis of the P2 region. A schematic representation of the divergent P2 region and the adjacent orc5 and sop2 genes is shown in the middle. DNA fragments cloned upstream of the luciferase reporter gene and used in the analysis of the sop2 promoter activity are shown above the schematic, and those used in the analysis of the orc5 promoter activity are shown below. The relative promoter activities of the constructs, as measured in the luciferase assay, are indicated to the right. The luciferase activity of the pxp2 vector was defined as 1.0 and was used as the standard for comparison. Luciferase activity was normalized to beta -galactosidase activity for each construct. Values are means ± S.D. of at least three independent experiments. Statistical analysis was carried out using the Wilcoxon signed-rank test. * indicates p < 0.05.

To evaluate the orc5 promoter, we assayed the activity of the orc-170/+346 construct and observed a high increase in luciferase activity, >8000-fold as compared with the pxp2 vector. The same region containing mutated DRE sites (orc-170/+346mut) directed significantly reduced activity, only 30% of that detected in the orc-170/+346 construct (p < 0.05). Thus, similar to the results obtained in the bidirectional rpII33/pol gamma -beta promoter region, the DRE sites located in the 5'-UTR of the orc5 gene are essential for the activity of one promoter (orc5), but have no effect on the activity of the other (sop2). More importantly, these data establish a common molecular mechanism involved in the regulated expression of two genes in the pol gamma  complex that are involved in nuclear and mitochondrial DNA replication, orc5 and pol gamma -beta , respectively.

DREF Binds to the pol gamma -beta and orc5 Promoter Regions-- To characterize further the DRE sequences in P1 and P2, we carried out electrophoretic mobility shift assays using probes covering the P1 and P2 regions that contain the DRE sites. We used either DREF produced by in vitro transcription/translation or nuclear extracts prepared from cultured Schneider's cells as the protein source. When a radiolabeled 173-bp fragment containing the single DRE site present in the P1 region (P1-DRE) was incubated with recombinant DREF protein, a single retarded protein-DNA complex was detected, which was eliminated when a 100-fold molar excess of unlabeled probe was included in the binding reaction (Fig. 6A). Inclusion of rabbit anti-DREF serum produced a clear supershift, demonstrating that DREF interacts with the DRE site in the pol gamma -beta promoter region. The supershift was also eliminated by inclusion of a 100-fold molar excess of unlabeled probe. When a similar experiment was carried out in which a 120-bp fragment containing the two DRE sites present in the P2 region (P2-DRE) was used as probe, similar results were obtained (Fig. 6B). In this case, two retarded protein-DNA complexes were apparent, and both were supershifted by the anti-DREF antiserum. As a control, we included preimmune serum in the binding reaction, and no supershift was produced. The same EMSA patterns were observed with both promoter fragments when the source of DREF was a nuclear extract prepared from Schneider's cells (Fig. 6, A and B).


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 6.   DREF binds to the DRE sites in the rpII33/pol gamma -beta and orc5/sop2 promoters. DREF binding was evaluated by EMSAs using recombinant DREF and nuclear extract from cultured Schneider's cells. Black arrows indicate the positions of retarded bands, and white arrows indicate supershifted bands. The probe for P1 (A) was a 173-bp DNA fragment spanning positions -325 to -153 (relative to the transcriptional start site at +1), and that for P2 (B) was a 120-bp DNA fragment from positions -132 to -13. The asterisk in the Ab AntiDREF lane in B indicates that preimmune serum was used. The competitors used were a 100-fold molar excess of the unlabeled DNAs used as probes. Ab, antibody.

Additional EMSA experiments were carried out with Schneider's cell nuclear extracts and functional DRE sequences that were characterized previously in the Drosophila mtSSB promoter as competitors (30). Here the probe for P1 was a double-stranded 30-mer oligonucleotide spanning positions -225 to -204 (Fig. 7A), and that for P2 was as described above (Fig. 7B). Both probes gave rise to shifted bands, and inclusion of anti-DREF antiserum in the binding reaction produced supershifts not observed upon inclusion of preimmune serum. When competition of DREF binding to P1 and the corresponding anti-DREF antiserum-mediated supershift was carried out using a 100-fold molar excess of unlabeled P1, P2, or ssb (a double-stranded oligonucleotide containing the two functional DRE sites in the mtSSB promoter (30)) DNA, the retarded bands and supershifts were abolished. However, if the competition was performed with ssb-/- DNA (a double-stranded oligonucleotide containing mutated DRE sites from the ssb promoter), neither the retarded bands nor the supershifts were eliminated, providing further support for the binding of DREF to P1. Similar results were obtained with DREF binding to P2. A 100-fold molar excess of P2 or ssb DNA eliminated the retarded bands and supershifts, but competition with ssb-/- DNA had no effect. Notably, however, only partial competition of DREF binding to the P2 region was observed with P1 DNA, likely due to the fact that P1 contains a single DRE site, whereas P2 contains two. Taken together, the EMSA experiments demonstrate that the DRE sites present in the pol gamma -beta and orc5 promoters are bound specifically by DREF.


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 7.   Functional DRE sequences compete for binding of DREF to the rpII33/pol gamma -beta and orc5/sop2 promoters. DREF binding to the P1 (A) and P2 (B) regions was examined by EMSAs with DRE-containing competitor DNAs. The probe for P1 was a double-stranded 30-mer oligonucleotide spanning positions -225 to -204, and that for P2 was as described in the legend Fig. 6. Black arrows indicate the positions of retarded bands, and white arrows indicate supershifted bands. The asterisk in the Ab AntiDREF lane in B indicates that preimmune serum was used. The competitors used were a 100-fold molar excess of the unlabeled P1 and P2 probes as indicated, ssb (a double-stranded oligonucleotide containing the two functional DRE sites in the mtSSB promoter (30)), and ssb-/- (the ssb probe with mutated DRE sites). Ab, antibody.

Analysis of the pol gamma -alpha Promoter Region (P3)-- A construct (alpha -1710/+113) containing the complete coding sequence of the sop2 gene, the ~140-bp sop2/pol gamma -alpha intergenic region, and 119 bp of the 5'-UTR of the pol gamma -alpha gene directed 300-fold higher luciferase activity than the pxp2 vector (Fig. 8). Constructs containing shorter DNA fragments maintained a similar level of activity, including construct alpha -407/+113, which contains only the sop2/pol gamma -alpha intergenic region and the pol gamma -alpha 5'-UTR. Luciferase activity was abolished in construct alpha -1197-183, which has the transcriptional start site eliminated. These data indicate that the proximal 5'-upstream region of the pol gamma -alpha gene has weak but significant promoter activity in Schneider's cells.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 8.   Functional analysis of the P3 region. A schematic representation of the P3 region, the adjacent sop2 gene, and the 5'-region of the pol gamma -alpha gene is shown. The NRF1-like sequence element is shown as an ellipse. DNA fragments cloned upstream of the luciferase reporter gene and used in the analysis of the pol gamma -alpha promoter activity are shown below. The relative promoter activities of the constructs, as measured in the luciferase assay, are indicated to the right. The luciferase activity of the pxp2 vector was defined as 1.0 and was used as the standard for comparison. Luciferase activity was normalized to beta -galactosidase activity for each construct. Values are means ± S.D. of at least three independent experiments. Statistical analysis was carried out using the Wilcoxon signed-rank test. * indicates p < 0.01.

The proximal 5'-upstream region of the pol gamma -alpha gene does not contain DNA sequence motifs with significant homology to the DRE site. However, its 5'-UTR contains a proximal binding motif potentially recognized by the transcription factor NRF1. To evaluate its functional relevance, we mutated the NRF1-like site. We observed a moderate but significant decrease (50%; p < 0.01) in the promoter activity of construct alpha -407/+113mut compared with the native construct alpha -407/+113, suggesting that the NRF1-like site might be functional in Schneider's cells.

NRF1 likely plays a key role in nucleo-mitochondrial communications in mammals (12). Interestingly, its DNA-binding motif is conserved in two regulatory proteins identified in Drosophila (Erect Wing) and sea urchin (P3A2). To study the binding of putative regulatory proteins to the NRF1-like site, we pursued EMSA experiments using, as probes, a double-stranded 35-mer oligonucleotide spanning positions +42 to +8 from the P3 region that contains the NRF1-like site (NRF1+) and a similar oligonucleotide containing a mutated NRF1-like site (NRF1-). When Schneider's cell nuclear extracts were incubated with the NRF1+ probe, several retarded bands were observed that were eliminated specifically by a 250-fold molar excess of unlabeled NRF1+ oligonucleotide as competitor (Fig. 9, left panel). Inclusion of anti-EWG antiserum in the binding reaction did not produce a supershift, suggesting that the EWG protein is not present in the retarded complexes. Competition with a 250-fold molar excess of the NRF1- oligonucleotide eliminated the retarded fragments, indicating that the protein bound to the probe likely interacts with sequence elements other than the NRF1-like site. Furthermore, when the NRF1- oligonucleotide was used as probe, several retarded bands were clearly visible, including an extra band not observed in the EMSAs with NRF1+ (Fig. 9, right panel). Whereas an excess of the NRF1- probe competed completely, only the shared retarded complexes were eliminated by a 250-fold excess of the NRF1+ oligonucleotide. These results suggest that there is protein binding to NRF1- that is mediated specifically through the mutant sequence, possibly explaining the inhibition of promoter activity detected in transient transfection experiments with the mutant NRF1-like construct (Fig. 8). This protein is not EWG because no supershift was observed in the EMSAs in the presence of anti-EWG antiserum. Overall, the data suggest that neither the EWG protein nor the native NRF1-like site per se is likely involved in the control of pol gamma -alpha promoter activity. Consistent with this interpretation, overexpression of EWG in Schneider's cells had no effect on the activity of the pol gamma -alpha constructs examined in transient transfection assays (data not shown).


View larger version (76K):
[in this window]
[in a new window]
 
Fig. 9.   Regulatory protein binding in the P3 region. Protein binding to the P3 region was examined by EMSAs. The probes were a double-stranded 35-mer oligonucleotide containing the NRF1-like site (NRF1+) and a derivative in which the NRF1-like site was mutated (NRF1-). Arrowheads indicate the positions of shared retarded bands, and the arrow indicates the position of the retarded band produced only with the NRF1- probe. The competitors used were a 250-fold molar excess of the unlabeled NRF1- (1) and NRF1+ (2) probes as indicated. Ab, antibody.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Eggs are highly enriched in mitochondria that are deposited by the mother during oogenesis. As development proceeds, important changes in the morphological and functional maturation of mitochondria occur (3) in a process that requires a careful orchestration of nucleo-mitochondrial interactions. Evidence from studies in different systems including mammals shows that the mitochondria stored in the egg are sufficient for the first stages of embryonic development (35). Later on, mitochondria are distributed throughout the various embryonic territories, which exhibit specific patterns of organelle differentiation (36). In Drosophila, the developmental pattern of expression of several genes encoding mitochondrial proteins, including the nuclearly encoded alpha - and beta -H+-ATP synthase subunits and the mitochondrially encoded ATPase-6 and -8 subunits, has been analyzed (37, 38). In each of these cases, gene expression is activated coordinately 6-12 h AEL, suggesting that during this period, the maternal contribution becomes limiting, and there is an activation of mitochondrial biogenesis in the embryo. Accordingly, it has been shown that mtDNA replication and likely mitochondrial proliferation start around this time of development (39).

In this work, we have evaluated the expression of the genes encoded in the pol gamma  cluster during Drosophila development and, in particular, those encoding the two subunits of the pol gamma  holoenzyme. Both pol gamma -alpha and pol gamma -beta mRNAs are stored in the egg, probably as a result of the high level of mtDNA replication occurring during oogenesis. The steady-state level of pol gamma -alpha mRNA declines rapidly during development, reaching a minimum level 10 h AEL and onward. In contrast, the pol gamma -beta mRNA level increases during the first hours of development and reaches its maximum level 6-10 h AEL. Nuclear run-on transcription analyses indicate that the expression of the genes encoding the two pol gamma  subunits is regulated differentially at the transcriptional level during Drosophila development. Notably, only the pol gamma -beta mRNA level is high in the period of active mtDNA replication. This might seem surprising because the pol gamma -alpha subunit contains the catalytic activities of the enzyme. However, the lack of correlation between the pol gamma -alpha mRNA level and mtDNA replication during Drosophila development is consistent with several results obtained previously in mammals. First, the pol gamma -alpha mRNA steady-state levels in different cell types do not correlate with their mtDNA content (40). Second, cells without mtDNA (rho 0) contain similar levels of pol gamma -alpha mRNA and protein compared with wild-type cells (41), rendering it unlikely that pol gamma -alpha serves a key role in the control of mtDNA replication. Although the steady-state level of pol gamma -beta mRNA has not been determined in mammals, its developmental profile in Drosophila suggests that the pol gamma -beta subunit participates in the reactivation of mtDNA synthesis during development. Interestingly, the pol